Laboratory Confirmation of Respiratory Syncytial Virus Infection Is Not Associated With an Increased Risk of Death in Adults With Acute Respiratory Illness - Takeaways - MDSpire

Laboratory Confirmation of Respiratory Syncytial Virus Infection Is Not Associated With an Increased Risk of Death in Adults With Acute Respiratory Illness

  • By

  • Jeffrey A Kline

  • Robert D Welch

  • Christopher Kabrhel

  • Daniel Mark Courtney

  • Carlos A Camargo

  • RESP-LENS site investigators

  • Michael J Roshon

  • Danielle E Turner-Lawrence

  • Michael A Puskarich

  • Ka Ming Gordon Ngai

  • Benton R Hunter

  • Joseph Bledsoe

  • James K d'Ettiene

  • Stephen S Lim

  • Christopher W Kabrhel

  • Esther J Choo

  • Steven M H Moore

  • Katherine R Buck

  • David M Beiser

  • James G Galbraith

  • Joby E Thoppil

  • Chris Kelly

  • Edward W Castillo

  • Israel E Green-Hopkins

  • Kristen S Nordenholz

  • Faheem C Guirgis

  • Bryan Wilson

  • Michael L Pulia

  • Stacey House

  • Justine M Pagenhardt

  • January 15, 2025

  • 0 min

Share

  • 1

    The study analyzed adults with acute respiratory illness (ARI) in emergency departments from August 2021 to March 2024.

  • 2

    Of 1,210,394 patients with ARI, 28.5% underwent RSV testing, with a positivity rate of 2.4%.

  • 3

    Mortality rates were 1.9% for RSV-positive adults and 2.9% for RSV-negative adults, with increased mortality in those aged 65 and older.

  • 4

    RSV positivity was not linked to higher hospitalization or 30-day mortality rates compared to RSV-negative patients.

  • 5

    Independent mortality risk factors included age ≥65 years, worsening vital signs, male sex, and heart failure.

Original Source(s)

Related Content